3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
11
Neoplasms
2
Mycosis Fungoides
2
Squamous Cell Carcinoma of Head and Neck
1
Sezary Syndrome
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphomatoid Papulosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
fludarabine phosphate
2
fludarabine
2
Cyclophosphamide
2
thymoglobulin
1
ruxolitinib
1
duvelisib
1
blinatumomab
1
Whole-Body Irradiation
1
Transplantation
1
Thiotepa
1
Tacrolimus
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Mesna
1
Melphalan
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Large Granular Lymphocytic
×
Brentuximab Vedotin
×
90 days
×
Clear all
No trials found.